Preoperative Cerebral and Renal Saturations in Neonates with Congenital Heart Defects: A Prospective Cohort Study
Issued Date
2025-01-01
Resource Type
ISSN
16617800
eISSN
16617819
Scopus ID
2-s2.0-105015762344
Pubmed ID
40701141
Journal Title
Neonatology
Rights Holder(s)
SCOPUS
Bibliographic Citation
Neonatology (2025)
Suggested Citation
Michel MacÍas C., Rampakakis E., Mir M., Mazzarello M., Moore S.S., Wutthigate P., Simoneau J., Villegas M D., Shemie S.D., Brossard-Racine M., Dancea A., Bertolizio G., Wintermark P., Altit G. Preoperative Cerebral and Renal Saturations in Neonates with Congenital Heart Defects: A Prospective Cohort Study. Neonatology (2025). doi:10.1159/000547589 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112113
Title
Preoperative Cerebral and Renal Saturations in Neonates with Congenital Heart Defects: A Prospective Cohort Study
Corresponding Author(s)
Other Contributor(s)
Abstract
Introduction: Congenital heart disease (CHD) is one of the most common birth defects. Cerebral (cStO<inf>2</inf>) and renal (rStO<inf>2</inf>) saturations measured by near-infrared spectroscopy (NIRS) and the corresponding fractional tissue oxygen extraction (FTOE) during the first week of life in neonates with CHD are described comparing those with and without diastolic steal. Methods: Single-center prospective cohort study (Montreal Children's Hospital, Montreal, QC, Canada) was conducted, including neonates >34 weeks with CHD without chromosomal anomalies. CStO<inf>2</inf>/rStO<inf>2</inf> was monitored from enrollment until day 7 of life. FTOE was calculated using systemic saturation (SpO<inf>2</inf>) as [SpO<inf>2</inf> - (cStO<inf>2</inf> or rStO<inf>2</inf>)]/SpO<inf>2</inf>. Daily echocardiography was performed during the monitoring period. Random mixed-effects models were constructed to assess the association between NIRS/FTOE and the presence of retrograde postductal aortic flow on last available echocardiography. Results: Among 49 included neonates, 27 (55%) exhibited retrograde flow in the postductal aorta on the last day of monitoring. Prostaglandin exposure was 100% in the retrograde group vs. 27% in the non-retrograde group. CStO<inf>2</inf>/rStO<inf>2</inf> progressively declined in neonates with CHD over the first week of life. Retrograde aortic flow was associated with negative cStO<inf>2</inf> (β = -9.1%, 95% CI [-14.3; -3.8]) and rStO<inf>2</inf> (β = -8.4%, 95% CI [-14.5; -2.3]). Cerebral FTOE was lower in the non-retrograde group, while renal FTOE was similar between groups. Conclusion: During the first week of life, neonates with CHD who displayed retrograde aortic flow exhibited lower cStO<inf>2</inf> and rStO<inf>2</inf> as well as higher cerebral FTOE. Future studies should evaluate whether these markers in neonates with CHD are modifiable factors that could influence cerebral or renal injury when addressed.